# Induction of Abortion in the Second Trimester

> **NCT06207539** · EARLY_PHASE1 · COMPLETED · sponsor: **Ain Shams Maternity Hospital** · enrollment: 40 (actual)

## Conditions studied

- Abortion, Second Trimester

## Interventions

- **DRUG:** hyoscine N-butyl bromide under the generic name of buscopan ampoule produced by Sanofi company
- **DRUG:** misoprostol under the generic name of misotac tablets

## Key facts

- **NCT ID:** NCT06207539
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207539, "Induction of Abortion in the Second Trimester". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT06207539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*